Skip to main content
Clinical Trials/CTRI/2023/03/050647
CTRI/2023/03/050647
Completed
Phase 3

Evaluation of antimicrobial capacity and bracket failure rate of riboflavin photosensitizer modified orthodontic bonding agent

Dr Thanish Ahamed0 sites22 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K02- Dental caries
Sponsor
Dr Thanish Ahamed
Enrollment
22
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 17, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Thanish Ahamed

Eligibility Criteria

Inclusion Criteria

  • 1\.Belonging to age group of 18\-25 years
  • 2\.Patients needing fixed orthodontic treatment with bonding in upper and lower arch using 0\.022 â??slot MBT prescription stainless steel orthodontic brackets and banding in first molars with no other auxiliaries required other than TPA in the maxilla.
  • 3\.Patients who donnot require therapeutic extraction of teeth
  • 4\.Healthy buccal enamel free of any enamel defects hypoplastic spots, fluorosis caries or restoration
  • 5\.Without crowding \-Arch length tooth material discrepancy not more than 2mm
  • 6\.Willing to give consent to participate in the study
  • 7\.Use of right hand while brushing the teeth

Exclusion Criteria

  • 1\.Presence active or untreated caries lesion, gingival inflammation or periodontal pockets
  • 2\.Presence of systemic disease
  • 3\.Presence of smoking habit, habit of chewing gums
  • 4\.Use of anti\-inflammatory or antibiotic medication within 3 months before the commencement of study
  • 5\.Fluoride therapy within 3 months before the commencement of study

Outcomes

Primary Outcomes

Not specified

Similar Trials